What's Happening?
Hers, a telehealth company, has introduced the Biotin-plus-Minoxidil Gummy, the first prescription gummy designed to support hair regrowth in women. This innovative product combines minoxidil, the only FDA-approved ingredient for female hair loss, with biotin, a vitamin known for promoting healthy hair, skin, and nails. The gummy offers a convenient, once-daily dose aimed at improving adherence to hair regrowth regimens. Dr. Jessica Shepherd, Hers' chief medical officer, emphasizes the gummy's design to cater to women's preferences, making treatment feel more like a self-care ritual.
AD
Why It's Important?
The introduction of a prescription gummy for hair loss represents a significant advancement in personal care, offering a more accessible and user-friendly option for women experiencing hair loss. By combining minoxidil with biotin in a gummy form, Hers addresses the challenge of treatment adherence, which is crucial for effective hair regrowth. This product could potentially transform the hair loss treatment market, providing women with a personalized and enjoyable way to manage their hair health. The gummy's launch highlights the growing trend of personalized medicine and telehealth solutions.
What's Next?
The Biotin-plus-Minoxidil Gummy is available through Hers after a virtual consultation with licensed providers. Each prescription is customized based on individual hair loss patterns and goals, with prices starting at $35 per month. Hers aims to offer affordable treatments without insurance, making it accessible to a wider audience. As the product gains traction, it may lead to further innovations in personalized hair care solutions. The success of this gummy could encourage other companies to explore similar approaches in addressing common health concerns.
